Diagonal Bio AB (publ) (DIABIO.ST)
SEK 0.01
(0.0%)
SEK 0.01
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 1.02 Million SEK | 0.0% |
| 2022 | - SEK | 0.0% |
| 2021 | - SEK | 100.0% |
| 2020 | -325.66 Thousand SEK | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | 1.36 Million SEK | 0.0% |
| 2024 Q1 | 1.66 Million SEK | 61.87% |
| 2024 Q2 | 1.36 Million SEK | -17.85% |
| 2023 FY | 1.02 Million SEK | 0.0% |
| 2023 Q4 | 1.02 Million SEK | 140.81% |
| 2023 Q3 | -2.51 Million SEK | -171.74% |
| 2023 Q2 | -926.99 Thousand SEK | -92700000.0% |
| 2023 Q1 | 1.00 SEK | 0.0% |
| 2022 FY | - SEK | 0.0% |
| 2022 Q4 | - SEK | 100.0% |
| 2022 Q3 | -807 Thousand SEK | 14.24% |
| 2022 Q2 | -941 Thousand SEK | 0.0% |
| 2022 Q1 | - SEK | 100.0% |
| 2021 Q1 | -281 Thousand SEK | 0.0% |
| 2021 FY | - SEK | 100.0% |
| 2021 Q3 | 1.00 SEK | 100.0% |
| 2021 Q2 | -339 Thousand SEK | -20.64% |
| 2021 Q4 | -466 Thousand SEK | -46600100.0% |
| 2020 Q4 | - SEK | 0.0% |
| 2020 FY | -325.66 Thousand SEK | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Alzinova AB (publ) | -3.27 Million SEK | 131.361% |
| Amniotics AB (publ) | 534 Thousand SEK | -92.509% |
| Asarina Pharma AB (publ) | - SEK | -Infinity% |
| BioArctic AB (publ) | - SEK | -Infinity% |
| Calliditas Therapeutics AB (publ) | 20.42 Million SEK | 94.968% |
| Saniona AB (publ) | 1.00 SEK | -102799900.0% |
| Simris Alg AB (publ) | 1.09 Million SEK | 5.775% |
| Vicore Pharma Holding AB (publ) | - SEK | -Infinity% |
| Scandinavian ChemoTech AB (publ) | 4.03 Million SEK | 74.517% |
| NextCell Pharma AB | 545.23 Thousand SEK | -88.542% |
| Elicera Therapeutics AB (publ) | -446.98 Thousand SEK | 329.985% |
| AcouSort AB (publ) | 2.08 Million SEK | 50.577% |
| Active Biotech AB (publ) | -2500.00 SEK | 41220.0% |
| Alligator Bioscience AB (publ) | 2.00 SEK | -51399900.0% |
| Camurus AB (publ) | 100.95 Million SEK | 98.982% |
| Cantargia AB (publ) | - SEK | -Infinity% |
| Genovis AB (publ.) | 14.9 Million SEK | 93.103% |
| Guard Therapeutics International AB (publ) | -1486.00 SEK | 69279.004% |
| Mendus AB (publ) | - SEK | -Infinity% |
| Kancera AB (publ) | -1950.00 SEK | 52817.949% |
| Karolinska Development AB (publ) | - SEK | -Infinity% |
| LIDDS AB (publ) | - SEK | -Infinity% |
| Lipum AB (publ) | - SEK | -Infinity% |
| Lipigon Pharmaceuticals AB (publ) | -1.62 Million SEK | 163.223% |
| Magle Chemoswed Holding AB (publ) | 35.22 Million SEK | 97.082% |
| Modus Therapeutics Holding AB (publ) | - SEK | -Infinity% |
| OncoZenge AB (publ) | -862.99 Thousand SEK | 219.119% |
| Xbrane Biopharma AB (publ) | 106.85 Million SEK | 99.038% |
| Xintela AB (publ) | 398 Thousand SEK | -158.291% |
| Ziccum AB (publ) | -4.18 Million SEK | 124.54% |
| Isofol Medical AB (publ) | - SEK | -Infinity% |
| Xspray Pharma AB (publ) | 43.78 Million SEK | 97.652% |
| CombiGene AB (publ) | -1.79 Million SEK | 157.143% |
| Diamyd Medical AB (publ) | 24.05 Million SEK | 95.726% |
| Intervacc AB (publ) | 10.48 Million SEK | 90.194% |
| Sprint Bioscience AB (publ) | -7.13 Million SEK | 114.406% |
| QuiaPEG Pharmaceuticals Holding AB (publ) | - SEK | -Infinity% |
| Corline Biomedical AB | -3.85 Million SEK | 126.653% |
| IRLAB Therapeutics AB (publ) | 1000.00 SEK | -102700.0% |
| Bio-Works Technologies AB (publ) | 9.06 Million SEK | 88.663% |
| Aptahem AB (publ) | - SEK | -Infinity% |
| Infant Bacterial Therapeutics AB (publ) | - SEK | -Infinity% |
| Fluicell AB (publ) | 3.15 Million SEK | 67.365% |
| Biovica International AB (publ) | 2.19 Million SEK | 53.251% |
| Spago Nanomedical AB (publ) | 1.00 SEK | -102799900.0% |
| Abliva AB (publ) | - SEK | -Infinity% |
| Egetis Therapeutics AB (publ) | 700 Thousand SEK | -46.857% |
| 2cureX AB (publ) | -1000.00 SEK | 102900.0% |
| I-Tech AB | 4.28 Million SEK | 75.981% |
| Hansa Biopharma AB (publ) | 9.79 Million SEK | 89.502% |
| Cyxone AB (publ) | - SEK | -Infinity% |
| ExpreS2ion Biotech Holding AB (publ) | - SEK | -Infinity% |
| Biosergen AB | -4.92 Million SEK | 120.856% |
| Nanologica AB (publ) | 2.97 Million SEK | 65.422% |
| SynAct Pharma AB | - SEK | -Infinity% |
| Annexin Pharmaceuticals AB (publ) | - SEK | -Infinity% |
| BioInvent International AB (publ) | 11.84 Million SEK | 91.32% |
| Stayble Therapeutics AB (publ) | -321.14 Thousand SEK | 420.105% |
| Oncopeptides AB (publ) | 2.42 Million SEK | 57.608% |
| Pila Pharma AB (publ) | 1.00 SEK | -102799900.0% |
| Ascelia Pharma AB (publ) | - SEK | -Infinity% |